Teva Appeals Singulair Patent Suit To Fed. Circ.
Teva Pharmaceutical Industries Ltd. has appealed an order barring it from making a generic version of Merck Sharpe & Dohme Pharmaceuticals SRL's allergy and asthma drug Singulair....To view the full article, register now.
Already a subscriber? Click here to view full article